本文对肝细胞移植的影响因素进行综述。
The influencing factors of hepatocyte transplantation were reviewed in this article.
目的研究肝细胞移植的临床应用及其最新研究进展。
Objective To investigate the application and advancement of hepatocyte transplantation (HCT).
目的：探讨微囊化猪肝细胞移植治疗大鼠急性肝衰竭的效果。
Objective: to investigate the therapeutic effect of microencapsulated pig hepatocyte transplantation on acute liver failure rats.
该研究的目的在于研究肝细胞移植在小鼠B型血友病模型中的效果。
The aim of this study was to investigate the efficacy of hepatocyte transplantation in the mouse model of hemophilia B.
现在的临床治疗方法包括肝脏移植、肝细胞移植、肝脏干细胞移植。
Clinically, the effective methods for its treatment include liver transplantation, liver cell transplantation and hepatic stem cell transplantation.
目的证实同种肝细胞移植排斥反应的存在并对其排斥机制作了初步探讨。
Objective To confirm the existence of allogeneic hepatocyte transplantation and investigate its mechanisms.
说明该永生化胚胎肝细胞可以成为生物人工肝及肝细胞移植研究中的理想细胞材料。
It is concluded that the immortalized human fetal hepatocytes would become i-deal cell material on the study of bioartificial liver and hepatocytes transplantation.
肝细胞微囊化有助于为肝细胞移植的推广应用提供大量的具有高度活性和良好功能的肝细胞。
Microencapsulated hepatocytes contribute to the promotion and application for liver cell transplantation, for which provide a large amount of high activity and good function of liver cells.
我们的研究使的研究人肝发育的潜在分子机制变得容易，并且形成肝细胞移植和药物实验的基础。
Our studies should facilitate searching the molecular mechanisms underlying human liver development, and form the basis for hepatocyte transplantation and drug tests.
文章回顾了肝细胞移植临床应用情况，并探讨肝细胞移植在临床应用中的价值及一些亟待解决的难题。
Here, we sum up the status of clinical hepatocyte transplantation, discuss its value in clinical application and some challenges need to resolve.
目的探讨胎肝胰岛细胞联合移植治疗糖尿病大鼠的效果，以及胎肝细胞移植诱导糖尿病受者鼠免疫耐受的可行性。
Objective to study the effect of combined transplantation of pancreatic islets and hepatocytes on the treatment of diabetic rats and the possibility on hepatocytes inducing islet allograft tolerance.
目的：本研究通过三个有序的小实验，分阶段探讨中药“养肝合剂”对进行肝细胞移植的急性肝衰竭大鼠的影响。
ObjectivesThis research through three ordered experiments to approach the effect of the Chinese medicine " Tonic Liver Mixture " to acute liver failure rats which have Hepatocyte transplantation.
该团队计划尽快使用该模型来研究他们是否能使用移植的胚胎和诱导的多向干细胞而不是成熟的肝细胞来产生器官。
The team plans to soon use the model to see whether they can generate organs using transplanted embryonic and induced pluripotent stem cells rather than mature liver cells.
方法回顾性分析3例因肝细胞癌接受肝脏移植病人的临床资料。
Methods The clinical data of 3 patients with hepatocellular carcinoma receiving orthotopic liver transplantation were analyzed.
尽管肝脏移植是治疗肝细胞癌的确认疗法，但目前不为首次治疗运用肝切除术的病人提供肝移植术。
But although liver transplantation is a recognized therapy for hepatocellular carcinoma, it is not currently offered to those who undergo hepatic resection as the first-line therapy, he notes.
新的辅助治疗被广泛用于降低肝细胞肿瘤以及延缓肿瘤恶化，以减少在等待移植时死亡的病患人数。
Neoadjuvant therapies are widely used to downstage hepatocellular tumors and slow the progression of tumors so that fewer patients die while waiting for transplants.
结论：交叉性别骨髓移植小鼠肝脏的基因表达谱变化规律为进一步研究骨髓形成肝细胞的分子机制奠定了实验基础。
Conclusion: the gene expression profile of bone marrow transplantation model have established a foundation to study the gene mechanism of bone marrow cells forming liver cells.
肝移植是肝细胞癌(HCC)患者最有希望的治疗选择之一。
Liver transplantation is one of the therapeutic methods with great promise to treat hepatocellular carcinoma (HCC).
结论从为肝细胞皮下移植可作为研究异种移植细胞性排斥反应的模型。
Conclusion So the subcutaneous hepatocellular transplantation can be used as the model to appreciate CMXR.
补救性供肝移植可用于初期行肝切除术后的反复肝细胞癌发生或肝功能恶化。
Salvage liver transplantation has been performed for recurrent hepatocellular carcinoma (HCC) or deterioration of liver function after primary liver resection.
背景：肝移植是对其它方法不可治疗的肝细胞癌（HCC）的一个公认的治疗方法。
BACKGROUND: Liver transplantation is an accepted treatment option for patients with otherwise untreatable hepatocellular carcinoma (HCC).
目的观察白细胞介素2（IL-2）基因修饰的小鼠肝细胞经脾内移植后对肝脏免疫功能的影响以及对肝癌小鼠的治疗作用。
Objective To investigate the effects of intrasplenically transplanted , IL-2 gene-modified hepatocytes on the liver immune response and anti-tumor activity. Methods Murine fetal hepatocytes BNLCL.
结论本研究所建立的裸鼠移植性人肝细胞肝癌模型成瘤率高，移植瘤生长良好，便于MRI观察，是一种适合于分子影像学研究的动物模型。
Conclusion The nude mouse model with FHCC, with ideal implantation and tumor growth rate, was convenient for MRI observation and suitable for molecular imaging research of human HCC.
结论肝细胞生长因子能显著促进大鼠减体积肝移植术后肝组织的再生，而对术后肝脏功能无明显损害作用。
Conclusion HGF improved liver regeneration after reduced-size liver transplantation in rats and has no negative effects on liver function.
方法建立移植瘤小鼠h 22肝细胞癌模型。
Methods The transplant tumor model of H22 hepatocarcinoma in mice was established.
方法建立稳定的大鼠肝移植模型，应用tu NEL方法检测肝移植术后肝细胞的凋亡。
Methods The hepatocellular apoptosis was examined by TUNEL method in stable transplantation models of rats.
结论肝移植术后血清醛缩酶、亮氨酸转肽酶和谷氨酸脱氢酶可作为新植入肝脏肝细胞损伤的有效指标，为临床治疗提供帮助。
Conclusion Serum ALD, LAP and GLDH levels are effective markers of hepatocellular damage after liver-transplantation and conducive to clinical therapy.
结论：这里我们鉴别了在等待肝移植的HCV -肝癌患者中，和肝细胞癌进展相关的基因。
CONCLUSIONS: Here, we have identified genes associated with HCC progression in HCV-HCC patients awaiting LT transplantation.
结论：这里我们鉴别了在等待肝移植的HCV -肝癌患者中，和肝细胞癌进展相关的基因。
CONCLUSIONS: Here, we have identified genes associated with HCC progression in HCV-HCC patients awaiting LT transplantation.
应用推荐